Extent of low-grade dysplasia in Barrett's esophagus: is it useful for risk stratification?
- PMID: 17335444
- DOI: 10.1111/j.1572-0241.2007.01067.x
Extent of low-grade dysplasia in Barrett's esophagus: is it useful for risk stratification?
Abstract
Low-grade dysplasia remains one of the great enigmas of Barrett's esophagus. Limited information is available on the natural history of this lesion, and studies suggest that cancer risk in patients with low-grade dysplasia is intermediate between that of intestinal metaplasia without dysplasia and high-grade dysplasia. Natural history studies of low-grade dysplasia are hampered by problems with interobserver variability among pathologists and sampling variability among endoscopists. To date, the extent of low-grade dysplasia has not been examined as a potential risk factor for the subsequent development of adenocarcinoma. Srivastava et al., in this issue of the American Journal of Gastroenterology, found that the extent of low-grade dysplasia, as measured by several different methods, was a risk factor for progression to cancer. While these findings are novel and provocative, it is premature to request your pathologist to count the number of crypts or biopsies with low-grade dysplasia just yet. However, these findings, if confirmed by studies utilizing a simpler measure of the extent of low-grade dysplasia, may help us determine the prognostic significance of this lesion in the future.
Comment on
-
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.Am J Gastroenterol. 2007 Mar;102(3):483-93; quiz 694. doi: 10.1111/j.1572-0241.2007.01073.x. Am J Gastroenterol. 2007. PMID: 17338734
Similar articles
-
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.Am J Gastroenterol. 2007 Mar;102(3):483-93; quiz 694. doi: 10.1111/j.1572-0241.2007.01073.x. Am J Gastroenterol. 2007. PMID: 17338734
-
Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.Aliment Pharmacol Ther. 2008 Feb 15;27(4):321-6. doi: 10.1111/j.1365-2036.2007.03579.x. Epub 2007 Nov 28. Aliment Pharmacol Ther. 2008. PMID: 18047565
-
Low-grade dysplasia in Barrett's esophagus has a high risk of progression.Endoscopy. 2007 Jul;39(7):581-7. doi: 10.1055/s-2007-966592. Endoscopy. 2007. PMID: 17611911
-
Dysplasia arising in barrett's esophagus: diagnostic pitfalls and natural history.Semin Diagn Pathol. 2002 Feb;19(1):12-9. Semin Diagn Pathol. 2002. PMID: 11936261 Review.
-
Histology of metaplasia and dysplasia in Barrett's esophagus.Surg Oncol Clin N Am. 2009 Jul;18(3):411-22. doi: 10.1016/j.soc.2009.03.011. Surg Oncol Clin N Am. 2009. PMID: 19500733 Review.
Cited by
-
Predictors of progression in Barrett's esophagus: current knowledge and future directions.Am J Gastroenterol. 2010 Jul;105(7):1490-1502. doi: 10.1038/ajg.2010.2. Epub 2010 Jan 26. Am J Gastroenterol. 2010. PMID: 20104216 Free PMC article. Review.
-
Risk factors for neoplastic progression in Barrett's esophagus.World J Gastroenterol. 2011 Aug 28;17(32):3672-83. doi: 10.3748/wjg.v17.i32.3672. World J Gastroenterol. 2011. PMID: 21990948 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
